EX-99.1 2 ea030188701ex99-1.htm PRESS RELEASE, DATED AUGUST 13, 2026 Exhibit 99.1 SS Innovations Reports Second Quarter 2026 Financial Results Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales FORT LAUDERDALE, FLA - August 13, 2026 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and six months ended June 30, 2026. The Company also filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, with the Securities and Exchange Commission on August 13, 2026. Second Quarter 2026 Overview Revenue increased 39.4% to $13.9 million from $10.0 million in the second quarter of 2025. Gross margin equaled 50.9%, compared to 59.1% in the second quarter of 2025. Gross profit rose 20.0% to $7.1 million from $5.9 million in the second quarter of 2025. Net loss of $2.7 million, or $(0.01) per diluted share, compared to a net loss of $0.3 million, or $(0.00) per diluted share, in the se…
Open exhibit ↗Current Report · Items 2.02, 7.01, 9.01 · 8-K
SS Innovations International Inc.
SSIINASDAQEQUITYCurrent
Results of Operations and Financial Condition · Regulation FD Disclosure
Item 2.02 Results of Operations and Financial Condition. The disclosure set forth in
Company context
We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. We design, manufacture and market an advanced, next-generation and affordable surgical robotic system called the SSi Mantra Surgical Robotic System (the “SSi Mantra”) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac surgeries. While surgical robotic systems have gained acceptance globally in the past two decades for providing greater efficiency, better clinical outcomes and reducing healthcare costs, access to such systems remains largely limited to developed countries such as the United States (the “U.S.”), the European Union (the “EU”) and Japan. With the SSi Mantra, we are breaking down barriers and accelerating access to surgical robotics technologies in underserved regions of the world.